This site is intended for Healthcare Professionals only.

Class 4 medicines defect information for Sevredol 10mg and 20mg tablets


Share post:

Napp Pharmaceuticals has noticed an error in the PIL of specific batches of Sevredol 10 mg Tablets and Sevredol 20 mg Tablets.

The affected batch numbers are 243406 and 244573 respectively.

“Healthcare professionals are advised to exercise caution when dispensing the product and where possible, provide an updated PIL,” the MHRA said, adding that there is no risk to product quality as a result of this issue, therefore the affected batches are not being recalled.

The error identified relates to approved safety-related variations to the PIL that were not implemented, resulting in an older version of artwork being used and packed within finished batches.

Below are listed the differences in the PIL text:

  • Section 2. What you need to know before taking Sevredol tablets – the addition of “severe asthma”
  • Section 2. Warnings and Precautions – the addition of “constipation”.
  • Section 2. Warnings and Precautions – the addition of “This medicine may cause breathing problems or worsen already existing problems while sleeping. These problems may include pauses in breathing during sleep, being awoken by shortness of breath, difficulty staying asleep or excessive daytime drowsiness. If you or someone else observes these symptoms contact your doctor. Your doctor may want to lower your dose.”
  • Section 2. Other medicines and Sevredol tablets – re-wording of an existing paragraph (no change in the overall meaning)
  • Section 4. Possible side effects – the addition of “Problems with breathing during sleep (sleep apnoea syndrome)”

Where available, Napp will be providing the updated PIL with all future deliveries for the affected batches.


Please enter your comment!
Please enter your name here

Current Issue December 2023

Related articles

Sanofi Consumer Healthcare signs supply agreements with two wholesalers

Opella Healthcare, trading as Sanofi Consumer Healthcare, said it has entered into a dual partnership agreement with Alliance...

Sigma 2024 Conference: Rishi Sunak sends best wishes to all the participants

The 14th Annual Community Pharmacy Conference by Sigma Pharmaceuticals began on Monday, 25 February at Sun City, South...

Peak Pharmacy branches in Derbyshire and Staffordshire find new owners

‘There is a resurgence in demand for pharmacies that dispense below 4,000 items’ Independent pharmacy chain, Peak Pharmacy, has...

JAS UK granted WDA(H) license for its pharma and healthcare division

Securing the license empowers JAS UK's pharma and healthcare division to seamlessly connect with the company’s more than...